Compare
Sangamo Therapeutics, Inc vs Kymera Therapeutics, Inc. vs C4 Therapeutics, Inc. vs X4 Pharmaceuticals, Inc
| Latest fiscal year | Sangamo Therapeutics, Inc SGMOQ | Kymera Therapeutics, Inc. KYMR | C4 Therapeutics, Inc. CCCC | X4 Pharmaceuticals, Inc XFOR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $39.55M | $39.21M | $35.95M | $35.11M |
| Revenue growth (YoY) | -31.6% | -16.7% | +1.0% | n/m |
| Gross margin | n/a | 0.0% (computed) | n/a | 83.6% (computed) |
| Operating margin | -306.5% | -891.1% | -320.5% | -247.4% |
| Net margin | -310.8% | -794.0% | -292.1% | -225.6% |
| Net income | -$122.93M | -$311.35M | -$104.99M | -$79.20M |
| EPS (Diluted) | -$0.44 | -$3.69 | -$1.27 | -$1.87 |
| Operating cash flow | -$97.21M | -$232.89M | -$98.69M | -$85.62M |
| Free cash flow | -$97.31M | -$234.34M | -$99.30M | -$85.62M |
| Cash & equivalents | $20.95M | $357.01M | $74.60M | $217.05M |
| Total assets | $59.74M | $1.74B | $359.07M | $290.46M |
| Total liabilities | $74.01M | $163.15M | $102.49M | $104.17M |
| Shareholders' equity | -$14.27M | $1.58B | $256.59M | $186.29M |
| Return on year-end equity | n/a | -19.7% | -40.9% | -42.5% |
| Shares outstanding | 350.69M | 81.32M | 96.91M | 90.91M |
Revenue, most recent five fiscal years
| Fiscal year | Sangamo Therapeutics, Inc | Kymera Therapeutics, Inc. | C4 Therapeutics, Inc. | X4 Pharmaceuticals, Inc |
|---|---|---|---|---|
| Latest | $39.55M Ended 2025-12-31 | $39.21M Ended 2025-12-31 | $35.95M Ended 2025-12-31 | $35.11M Ended 2025-12-31 |
| 1 year earlier | $57.80M Ended 2024-12-31 | $47.07M Ended 2024-12-31 | $35.58M Ended 2024-12-31 | $2.56M Ended 2024-12-31 |
| 2 years earlier | $176.23M Ended 2023-12-31 | $78.59M Ended 2023-12-31 | $20.76M Ended 2023-12-31 | $0 Ended 2023-12-31 |
| 3 years earlier | $111.30M Ended 2022-12-31 | $46.83M Ended 2022-12-31 | $31.10M Ended 2022-12-31 | $0 Ended 2022-12-31 |
| 4 years earlier | $110.70M Ended 2021-12-31 | $72.83M Ended 2021-12-31 | $45.78M Ended 2021-12-31 | $0 Ended 2021-12-31 |